Norman Gaylis

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

Josef S Smolen, Jonathan Kay, Mittie K. Doyle et al. · The Lancet · 2009 · 516 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +11

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 479 citations

Rheumatoid Disorder, Rheumatology, Tofacitinib Monotherapy +8

Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial

Philip J. Mease, Stanley Cohen, Norman Gaylis et al. · The Journal of Rheumatology · 2010 · 123 citations

Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study

Mark C. Genovese, Norman Gaylis, David Sikes et al. · The Lancet Rheumatology · 2020 · 103 citations

Rheumatoid Disorder, Rheumatology, Stimulation Device +10

Infliximab in the treatment of an HIV positive patient with Reiter's syndrome.

Norman Gaylis · PubMed · 2003 · 102 citations

Hiv Viral Load, Immunodeficiencies, Immunology +17